Vol 4, No 3 (September 2013): Journal of Gastrointestinal Oncology

Editorial

Targeted therapies in colorectal cancer: the dos, don’ts, and future directions

Marwan Fakih

PDF Pages: 239-244 Full Text (4002) Open Access

Review Articles

Status of targeted therapies in the adjuvant treatment of colon cancer

Valerie M. Nelson, Al B. Benson III

PDF Pages: 245-252 Full Text (5398) Open Access

Understanding and targeting resistance to anti-angiogenic therapies

Jeffrey M. Clarke, Herbert I. Hurwitz

PDF Pages: 253-263 Full Text (20544) Open Access

The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers

Rob Glynne-Jones, Maher Hadaki, Mark Harrison

PDF Pages: 264-284 Full Text (6796) Open Access

Integrating anti-EGFR therapies in metastatic colorectal cancer

Sigurdis Haraldsdottir, Tanios Bekaii-Saab

PDF Pages: 285-298 Full Text (11120) Open Access

Continuum of care with anti-angiogenic therapies in metastatic colorectal cancer

Brandon G. Smaglo, Jimmy Hwang

PDF Pages: 299-307 Full Text (4110) Open Access

Markers of resistance to anti-EGFR therapy in colorectal cancer

Walid Shaib, Reena Mahajan, Bassel El-Rayes

PDF Pages: 308-318 Full Text (8126) Open Access

A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers

Christopher Urban, Milan J. Anadkat

PDF Pages: 319-327 Full Text (12908) Open Access

Targeted therapies in colorectal cancer: surgical considerations

Carrie Luu, Amanda K. Arrington, Hans F. Schoellhammer, Gagandeep Singh, Joseph Kim

PDF Pages: 328-336 Full Text (8897) Open Access